What is Polarean Imaging plc?
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States.
PLLWF · Verdict
Moderate reward · moderate risk
PLLWF stands out on volatility and growth, but watch the cash flow signal.
Based on 88% data coverage
PLLWF · Verdict
Top decile vs peers
Rev +37.6% CAGR · earnings -15.2%
Above average
-188% free-cash-flow margin
-276% net margin · -81% ROE
Model-based scoring. For information only — not financial advice.
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 7.97M.
The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.